Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1998-06-03
2000-10-31
Leary, Louise N.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 23, 435 24, 435 4, 530300, 530330, 530350, C12Q 102, C12Q 137, C12Q 100
Patent
active
061400688
ABSTRACT:
Assays employing fibronectin-depleted substrates are described to identify invasion inducing agents. Such agents are useful for in vivo wound healing, including but not limited to deep wounds and chronic wounds.
REFERENCES:
patent: 5051448 (1991-09-01), Shashoua
patent: 5136023 (1992-08-01), Hashino et al.
patent: 5169862 (1992-12-01), Burke, Jr. et al.
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5492890 (1996-02-01), Ginsburg et al.
patent: 5539085 (1996-07-01), Bischoff et al.
patent: 5559103 (1996-09-01), Gaeta et al.
patent: 5576423 (1996-11-01), Aversa et al.
Hunt and Goodson, "Current Surgical Diagnosis & Treatment" (Way; Appleton & Lange), pp. 86-98 (1988).
M. Harris et al., "Prevalence of Diabetes and Impaired Glucose Tolerance and Glucose Levels in the US Population aged 20-74 Years," Diabetes, 36:523 (1987).
Winter, "Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the skin of the Young Domestic Pig," Nature, 193:293-94 (1962).
Kannon and Garret, "Moist Wound Healing with Occlusive Dressings," Dermatol. Surg., 21:583-590 (1995).
Davies, "Synthetic Material for covering burn wounds: Progress towards perfection. Part 1. Short term dressing materials," Burns, 10:94 (1983).
Riley, "Wound Healing," Am. Fam. Physician, 24:107 (1981).
D. Livant et al., "Invasion of Selectively Sea Urchin Embryo Basement Membranes by Metastic Tumor Cells, But Not By Their Normal Counterparts," Cancer Research, 55:5085 (1995).
Eldred et al., "Orally Active Non-Peptide Fibrinogen (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoiminomethyl) phenyl]-1-piperazinyl]-1-piperidineactic Acid as a Long-Acting, Broad Spectrum Antithrombotic Agent," J. Med. Chem., 37:3882 (1994).
Ku et al., "Potent Non-Peptide Fibrinogen Receptor Antagonists Which Present An Alternative Pharmacophore," J. Med. Chem., 38:9 (1995).
W.R. Pearson and D.J. Lipman, "Improved Tools for Biological Sequence Comparison," Proc. Natl. Acad. Sci. (USA), 85:2444-2448 (1988).
D.J. Lipman and W.R. Pearson, "Rapid and Sensitive Protein Similarity Searches," Science, 227:1435-1441 (1985).
D.F. Mosher, "Physiology of Fibronectin," Ann. Rev. Med., 35:561 (1984).
P. Huhtala et al., "Cooperative Signaling by .alpha.5.beta.1 and .alpha.4.beta.1 Integrins Regulates Metalloproteinase Gene Expression in Fibroblasts Adhering to Fibronectin," J. Cell. Biol., 129:867 (1995).
Greiling and Clark, "Fibronectin provides a conduit for fibroblasts transmigration from collagenous stroma into fibrin clot provisional matrix," J. of Cell Science, 110:861-870 (1997).
Clark et al., "Cryptic Chemotactic Activity of Fibronectin for Human Monocytes Resides in the 120 kDa Fibroblastic Cell-binding Fragment," J. Biol. Chem., 263: 12115-12123 (1988).
Clark et al., "Fibronectin and Fibrin Provide a Provisional Matrix for Epidermal Cell Migration During Wound Reepithelialization," J of Invest. Dermatol., 79:264-269 (1982).
Clark, "Fibronectin Matrix Deposition and Fibronectin Recpetor Expression in Healing and Normal Skin," J. of Invest. Dermatol., 94(6): 128S-134S (1990).
Aota, S. et al., "The Short Amino Acid Sequence Pro-His-Ser-Arg-Asn in Human Fibronectin Cell-Adhesive Function," J. Biol. Chem., 269(40): 24756-24761 (1994).
Aota, S. et al., "Characterization of Regions of Fibronectin Besides the Arginine-Glycine-Aspartic Acid Sequence Required for Adhesive Function of the Cell-binding Domain Using Site-directed Mutagensis," J. Biol. Chem., 266(24): 15938-15943 (1991).
O'Donnell et al., "Structure-Activity Studies of Vasoactive Intestinal Polypeptide," J. of Biol. Chemistry, vol. 266,10:6389-6392 (1991).
Leary Louise N.
The Regents of the University of Michigan
LandOfFree
Protease resistant compositions for wound healing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease resistant compositions for wound healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease resistant compositions for wound healing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2049935